Edition:
United States

Bayer AG (BAYZF.PK)

BAYZF.PK on OTC Markets Group

103.80USD
27 Jul 2016
Change (% chg)

$2.76 (+2.73%)
Prev Close
$101.04
Open
$103.85
Day's High
$103.85
Day's Low
$103.80
Volume
794
Avg. Vol
7,002
52-wk High
$148.26
52-wk Low
$94.95

Select another date:

Wed, Jul 27 2016

BRIEF-Bayer CFO says no need to rush into Covestro share sale

* CFO Johannes Dietsch says no need to rush into any Covestro share sale transaction, no need to pile up further cash at the moment

Bayer drugs secure earnings beat, offset weak crop chems

FRANKFURT Bayer , the German drugmaker trying to acquire U.S. seed company Monsanto , surpassed second-quarter earnings expectations and raised its guidance for the year as strong gains in stroke prevention pill Xarelto offset sluggish farming pesticides markets.

UPDATE 1-Bayer drugs secure earnings beat, offset weak crop chems

* Shares seen up 0.7 pct in premarket trades (Adds details on Xarelto, Eylea, Crop Chemicals unit, background on Monsanto)

Bayer's drugs unit secures Q2 earnings beat

FRANKFURT, July 27 Bayer, the German drugmaker trying to acquire U.S. seed company Monsanto, easily surpassed second-quarter earnings expectations and raised its full-year guidance on strong gains in stroke prevention pill Xarelto and anti-blindness drug Eylea.

Plaintiffs seek MDL for Bayer Essure cases

Plaintiffs' lawyers have asked a federal judicial panel to create a new multidistrict litigation for a growing number of cases alleging Bayer's Essure contraceptive device can cause debilitating injuries.

Monsanto rejects Bayer's sweetened offer, open to talks

U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG , but said it was open to further talks with the German healthcare and chemicals group as well as other parties.

UPDATE 6-Monsanto rejects Bayer's sweetened offer, open to talks

* Monsanto shares rise 0.3 pct; Bayer off 1.2 pct (Adds Bayer statement, updates shares)

Monsanto rejects Bayer's sweetened offer, open to talks

By Greg Roumeliotis, Ludwig Burger, Swetha Gopinath and Amrutha Gayathri

BRIEF-Monsanto views Bayer's revised proposal as financially inadequate, insufficient to ensure deal certainty

* Monsanto views Bayer's revised proposal as financially inadequate and insufficient to ensure deal certainty

Monsanto says Bayer's sweetened offer inadequate

July 19 U.S. seed company Monsanto Co said a sweetened $125-per-share offer from German chemicals group Bayer AG was "financially inadequate and insufficient to ensure deal certainty."

Select another date: